Moderna Inc (MRNA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Moderna Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
MRNA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Moderna Inc's variance in analysts' estimates is lower than 5.68000000000001% of all US stocks.
- The average analyst price target of MRNA is higher than 92.29% of Pharmaceutical Products stocks.
- Moderna Inc's percent of analysts bearish on the stock is lower than 8.8% of Pharmaceutical Products stocks.
- The number of analysts covering the stock of MRNA is greater than 90.89% of Pharmaceutical Products stocks.
- Moderna Inc's upside potential (average analyst target price relative to current price) is higher than 13.13% of Pharmaceutical Products stocks.
- The percentage of analysts bullish on the stock of MRNA is greater than 69.5% of stocks in the large market cap category.
- The change in bullishness amongst analysts of MRNA is lower than just about 100% of all US stocks.
What is the outlook for MRNA? Use POWR Ratings for clearer insight into price direction.